Fluorescent labeling of SPOCK1 and localization studies in live neural cell lines

Download

ZEK-Thesis-26.12.2022.pdf

Date

2022-11-30

Author

Karaboğa, Zeynep Eda

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

269
views

105
downloads

Alzheimer's disease is the most common form of dementia and is incurable. The late onset Alzheimer’s disease (LOAD) is associated with complex genetic transition, and the molecular background has not been enlightened yet. Our previous research on the meta-analysis of genome-wide association studies (GWAS) showed a statistical correlation between SPOCK1 variants and LOAD. Also, it is co-regulated with apolipoprotein (APP), one of the proteins clinically linked with LOAD. Furthermore, the SPOCK1 protein recently had considerable attention due to its role in cell adhesion in various cancers. Considering the current literature on SPOCK1, we hypothesized that SPOCK1 might impact Alzheimer's pathogenesis in neural cells. In this study, human neuroblastoma and astroglia cells expressing fluorescent tagged SPOCK1 were constructed to study the expression and localization of SPOCK1. IHC and confocal image analysis with various organelle labels were performed, and co-localization data showed SPOCK1 localized in mitochondria for both neuroblastoma and astroglial cells. The data obtained in this study related to the localization of SPOCK1 in vitro could contribute to the research of the molecular background of Alzheimer’s disease in the future.

Subject Keywords

SPOCK1 gene, SPOCK1 protein, LOAD, Neural cell lines

URI

https://hdl.handle.net/11511/101259

Collections

Graduate School of Natural and Applied Sciences, Thesis

Suggestions

OpenMETU
Core

COMPARATIVE ANALYSIS OF BRAIN CELL CULTURES AND TISSUES IN ALZHEIMER’S DISEASE BASED ON DIFFERENTIAL EXPRESSION AND GENE SET ENRICHMENT Burduroğlu, Hüseyin Cahit; Aydın Son, Yeşim; Department of Bioinformatics (2023-1-25) Alzheimer’s disease is currently the most common cause of dementia in the world. It is a neurodegenerative disease that is diagnosed neuropathologically by observing B-amyloid plaques and neurofibrillary tangles in the brain. Transcriptional differentiations, protein regulations, and the interactions in between have been investigated by recent studies to understand from which brain cell type the disease stems, such as microglia, astrocytes, and neurons. These studies are mostly performed on brain tiss...
Investigating conversion from mild cognitive impairment to alzheimer's disease using latent space manipulation Ayvaz, Deniz Sezin; Baytaş, İnci M. (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10) Alzheimer’s disease, a progressive neurologic disorder, is the most common cause of dementia, affecting millions worldwide. Mild Cognitive Impairment (MCI) is considered an intermediate stage before Alzheimer's. Early prediction of the conversion from MCI to Alzheimer's is crucial to take necessary precautions for decelerating the disease progression and developing suitable treatments. This study proposes a deep learning framework to identify patients whose diagnoses might change from MCI to Alzheimer’s in ...
Gene-level pathogenicity scores for alzheimer’s disease using genomic variants from rna-seq data Bozkurt, Fatma Betül; İlgün, Atılay; Uzuner, Dilara; Çakır, Tunahan (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10) Alzheimer’s disease (AD) is a complex neurodegenerative disorder affecting millions of people worldwide. Next-generation sequencing technologies such as whole-exome/genome sequencing have been widely used for detecting the variants in the genome to understand the disease etiology and unravel underlying molecular mechanisms. Alternatively, RNA-Seq data can also be used to detect variants. Since AD is a complex disease, several variants are involved in the disease pathogenesis. By using scoring algorithms, it...
Personalized analysis of metabolic changes in Alzheimer's disease with a systems biology approach Uzuner, Dilara; Düz, Elif Emanetçi; ilgün, Atılay; Bozkurt, Fatma Betül; Çakır, Tunahan (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10) Alzheimer's disease (AD) is a multifactorial neurodegenerative disease without a cure. Metabolic changes are known to take place in the brains of patients. Metabolic reactions are catalysed by enzymes coded by genes. Therefore, genetic mutations can indirectly affect metabolic changes. Genome scale metabolic models (GEMs) are common tools used in systems biology to understand changes in metabolism. GEMs include all metabolic reactions and reaction-enzyme-gene relationships in the organism. Integrative Metab...
Comparison of social support perceptions of caregivers of cancer and dementia patients Yorulmaz, Elçin; Çıvgın, Umut; Bozo Özen, Özlem (2019-07-02) Cancer and dementia are two of those diseases that require care. Caring for the patients with such diseases is challenging for caregivers and is associated with many psychological health outcomes (e.g. Coope et al., 1995; Vanderwerker et al., 2005). Of all caregivers, the ones giving care to dementia patients were found to be affected more negatively than others by the caregiving process (Pinquart & Sörensen, 2003). Thus, it seems to be important to examine the underlying factors of this difference. Percept...

Citation Formats

Z. E. Karaboğa, “Fluorescent labeling of SPOCK1 and localization studies in live neural cell lines,” M.S. - Master of Science, Middle East Technical University, 2022.